
![]() |
|||||||||||||
WJPR Citation
|
| All | Since 2020 | |
| Citation | 8502 | 4519 |
| h-index | 30 | 23 |
| i10-index | 227 | 96 |
A REVIEW ON CAUSES, STAGES AND TREATMENTS USED IN ALZHEIMER'S DISEASE
Diptesh T. Patil*, Aditya Singh and Dr. Vanita Kanase
Abstract Alzheimer’s disease (AD) is a chronic progressive neurodegenerative disorder which reduced the person’s ability to think clearly, perform everyday tasks and ultimately, remember who they even are. As it worsens over the time, patient must get early detection and proper treatment. Cholinesterase inhibitors are used as a first line of defence to treat the cognitive symptoms (memory loss, confusion, and problems with thinking and reasoning) of AD. As new targets are hypothesized and new drugs are in phase 2-3 clinical trials soon the better therapeutic effect may be achieved. The proper harmony must involve between pharmacological treatments with nonpharmacological treatments. Keywords: Donepezil, Huperazine A, Memantine, Rivastigmine, GTS-21, Statins, Coenzyme Q. [Full Text Article] [Download Certificate] |
